Our nationally-ranked cancer experts aren't just on our team. They're on yours. We're here for you during your treatment and long after. Learn More>
Making an appointment is more convenient than ever. Call 1-800-JEFF-NOW to speak with a representative, or
Among the Nation's Best for Cancer
U.S. News has named Jefferson among the best hospitals in the nation for Cancer care.
Lung cancer is the second most common cancer in the United States. More people die of lung cancer than colon, breast and prostate cancers combined. However, lung cancer screenings and emerging research into biomarkers, nonsurgical approaches to biopsy, novel therapies involving radiotherapy and immunotherapy are giving hope to patients.
Your lungs are a pair of sponge-like organs inside your chest. Lung cancer starts in lung tissue, while malignant (cancerous) cells start elsewhere in the body and metastasize (spread) to the lungs.
Lung Cancer Types
Knowing which type you have affects your prognosis and treatment. There are two main types of lung cancer:
Small cell lung cancer, which accounts for about 10 to 15 percent of lung cancers.
Non-small cell lung cancer, which accounts for about 80 to 85 percent of all lung cancers. There are different subtypes of non-small cell lung cancer, including:
- Lung Adenocarcinoma accounts for about 40 percent of lung cancers, and grow more slowly than other types of lung cancer.
- Large Cell Lung Cancer represents approximately 10 percent of lung cancers. It can appear in any part of the lung. It tends to grow and spread quickly. A subtype of large cell lung cancer, known as large cell lung neuroendocrine carcinoma, represent fewer than five percent of lung cancers.
- Squamous Cell Lung Cancer accounts for about 30 percent of all lung cancers. This type of lung cancer is typically found in the middle of the lungs.
Lung Cancer Screenings
Early lung cancer detection and diagnosis is exceptionally important for good outcomes. Our Lung Cancer Screening Program is a unique, one-day, low-cost service that relies on state-of-the-art screening methods for high-risk patients.
Jefferson is one of only a few hospitals in the nation offering an advanced level of diagnostic testing programs, including low-dose computed tomography (LDCT), which obtains a multiple-image scan of the entire chest compared to standard X-rays that produce a single image of the whole chest.
If you think you may be at an increased risk of developing lung cancer because of your genetics, the experts at Jefferson’s Clinical Cancer Genetics Service can provide genetic risk assessment, genetic counseling and genetic testing.
Why Choose Jefferson for Lung Cancer?
The Sidney Kimmel Cancer Center – Jefferson Health and Jefferson’s Lung Nodule Clinic are your Philadelphia area resources for nationally-recognized oncology expertise. We’re rated as one of the nation’s best hospitals for cancer treatment by U.S.News & World Report, and we are one of only 70 National Cancer Institute NCI-designated Cancer Centers in the United States.
Jefferson is proud to have many one-of-a-kind programs including our Thoracic Oncology Program that provides an advanced level of lung cancer treatment and research focused on addressing every aspect of your care. Our Jane and Leonard Korman Respiratory Institute — Jefferson Health and National Jewish Health was formed to better understand lung disease through innovative research and expanded clinical programs for exceptional patient care.
At Jefferson, we not only offer our patients best-in-class lung cancer medical services, our compassionate care includes a support program to meet your emotional and psychological needs, too.
Clinical trials are the best way patients can receive new therapies and procedures. To find out if a clinical trial might be right for you, ask your health care provider or contact the Sidney Kimmel Cancer Center Clinical Research Management Office at 215-955-1661.
Next-Day Appointments Available
Call 1-800-JEFF-NOW (1-800-533-3669) to speak with a JEFF NOW® representative who will schedule an appointment for you.